肿瘤免疫学与免疫治疗/ Tumor Immunology and Immunotherapy

生物论坛 会议展会
时间: 2017/10/22 至 2017/10/26 地点:qiyue road 299,suzhou,jiangsu prov.china 主办单位: 冷泉港亚洲 承办单位: 冷泉港亚洲 官方网址: http://www.csh-asia.org/ 会议简介 | 联系方式 发布肿瘤免疫学与免疫治疗/ Tumor Immunology and Immunotherapy的新闻报道 订阅会议 报名已结束,你可订阅会议 会议简介

摘要截止日: August 11, 2017 科学组委 曹雪涛,中国医学科学院/第二军医大学/浙江大学,中国 Vincenzo Cerundolo,University of Oxford, UK Olivera Finn,University of Pittsburgh, USA Pramod Srivastava,University of Connecticut, USA 会议主题 1. Defining tumor antigens and immunogenicity 2. Immune checkpoint blockade and antibody therapy 3. Adoptive T cell therapy 4. Vaccine-based immunotherapy 5. Gut microbiota, immunity and cancer 6. Inflammation, tumor microenvironment and immune escape 7. New approach to cancer immunotherapy 主题演讲 Robert Schreiber,Washington University, School of Medicine, USA Laurence Zitvogel,Institut Gustave Roussy(IGR), FRANCE 特邀演讲 Jay Berzofsky,National Cancer Institute, NIH, USA 曹雪涛,中国医学科学院/第二军医大学/浙江大学,中国 Vincenzo Cerundolo,University of Oxford, UNITED KINGDOM Adelheid Cerwenka,German Cancer Research Center, GERMANY Phillip Darcy,Peter MacCallum Cancer Institute, AUSTRALIA Olivera Finn,University of Pittsburgh School of Medicine, USA Yang-Xin Fu,UT Southwestern Medical Center, USA Dmitry Gabrilovich,The Wistar Institute, USA Guido Kroemer,Institute Gustav Roussy, FRANCE Alberto Mantovani,Humanitas Clinical and Research Center, ITALY Augusto Ochoa,Louisiana State University Health Sciences Center, USA Pamela Ohashi,Princess Margaret Hospital, CANADA Suzanne Ostrand-Rosenberg,University of Maryland, USA Bruce Robinson,The University of Western Australia, AUSTRALIA Michel Sadelain,Memorial Sloan Kettering Cancer Center, USA Pramod Srivastava,University of Connecticut Health School of Medicine, USA 田志刚,中国科学技术大学,中国 Dario Vignali,University of Pittsburgh, USA Weiping Zou,University of Michigan Medical School, USA 9月25日前注册缴费享早鸟价,详情请见官网http://www.csh-asia.org/2017meetings/Immune.html

联系方式

联系人:薛女士

E-mail:

电话:+8651262729029

地址:qiyue road 299,suzhou,jiangsu prov.china

相关文章
评论留言